Researchers at the Weizmann Institute have discovered that sildenafil, the active ingredient in Viagra, may stop the spread of cancer by blocking the supply of cholesterol to cancer cells, showing promising results in studies on mice and in a large group of patients, suggesting the need for further clinical studies, especially in women with triple-negative breast cancer. (translated)















